RxDoctor Payments Data

Ranjan Ginde, DO

Internal Medicine · Paramus, NJNPI 1093020513

Payments from drug & device makers

$274in general payments, 2019–2025

Across 15 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$48
  • Lilly USA, LLC$40
  • Astellas Pharma US Inc$35
  • Abbott$31
  • Novo Nordisk$31
  • Boston Scientific$31
  • plus $60 from 3 others

What the payments were for

  • Food & beverage$274100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$274 in reported general payments places this provider in the 45th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$7,102
Medicare patients
31
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban12$7,577
Atorvastatin Calcium26$384

Paid to pharmacies, not to this prescriber.

Other internal medicine in Paramus

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →